Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U300 in the Netherlands: Evidence From a Randomised Controlled Trial

INTRODUCTION: This study aimed to evaluate the short-term cost-effectiveness of insulin degludec 200 units/mL (degludec) versus insulin glargine 300 units/mL (glargine U300) from a Dutch societal perspective. METHODS: A previously published model estimated costs [2018 euros (EUR)] and effectiveness...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Adv Ther
Hoofdauteurs: Evans, Marc, Moes, Robert G. J., Pedersen, Katrine S., Gundgaard, Jens, Pieber, Thomas R.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer Healthcare 2020
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7467476/
https://ncbi.nlm.nih.gov/pubmed/32306247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-020-01332-y
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items